[ad_1]
KBW has upgraded Bank of New York Mellon to an “Outperform” rating, supported by a strong financial performance and a low price-to-earnings valuation.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...